Around the world there is a rapidly growing body of scientific evidence suggesting that psychedelic drugs are safe and highly effective when used under medical supervision. Why did promising [...]
Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon
People who use drugs understand drugs and drug use in ways that are often different to the way knowledge of drug use is constructed within the dominant medico-legal discourse. Their experiences [...]
There’s a landmark project underway in Melbourne to find out whether psilocybin – the hallucinogenic compound in magic mushrooms – can be used to improve end-of-life [...]
This presentation was delivered by PRISM President Dr Martin Williams at a fundraising seminar and dinner held at The Melbourne Brain Centre, Parkville on 8th April 2016.
Dr Martin Williams, president of Psychedelic Research in Science & Medicine talks on ABC Radio Alice Springs
MDMA — more commonly known as ecstasy — is one step closer to becoming a legal form of treatment for post-traumatic stress disorder (PTSD) in the United States.
A recent review in Pharmacological Reviews highlights that over the last decade, a renaissance has occurred in psychedelic drug research
When Martin Williams’ research plan was first rejected by an ethics committee in 2012, he understood why. The medicinal chemistry researcher could see some valid sticking points.
Click here to listen: https://soundcloud.com/enpsychedelia/the-psychedelic-inquirer-prism-interview
Martin Williams from PRISM talks to The Feed at SBS TV: Post-Traumatic Stress Disorder is often a symptom of prolonged violence, sexual abuse, wars, and serious accidents.
PRISM will be presenting a panel discussion at the 2013 Australian Professional Society on Alcohol and other Drugs Scientific Conference 24-27 November in Brisbane.